Life Science Tools Market (By Technology: Genomics, Cell Biology, Proteomics, Lab Supplies & Technologies, and Others ; By Product: Consumables, Instruments, Services; By End-use: Academic and Research Institutions, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, CROs, Government and Regulatory Agencies) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Life Science Tools Market, By Product

7.1. Life Science Tools Market, by Product Type, 2024-2033
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast (2021-2033)
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast (2021-2033)
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast (2021-2033)
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast (2021-2033)
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast (2021-2033)
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast (2021-2033)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Life Science Tools Market, By End-User

8.1. Life Science Tools Market, by End-User, 2024-2033
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Life Science Tools Market, By Technology

9.1. Life Science Tools Market, by Technology, 2024-2033
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.5.3. Market Revenue and Forecast, by Technology (2021-2033)

Chapter 11. Company Profiles

11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample